Kansas City Clinical Neuroscience Society Inc (EIN 822635737) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Legal Domicile

Principal Officer

Abe Teferra

Tax Period

2023-01-01 to 2023-12-31

Kansas City Clinical Neuroscience Society Inc is a small nonprofit in the Public & Societal Benefit sector that reported $309K in total revenue in fiscal year 2023. Revenue surged 24% from the prior year, signaling strong growth momentum.

Mission

The Kansas City Clinical Neuroscience Society, Inc. (KCCNS) provides education for members by disseminating information and knowledge on all aspects of the neurological sciences. KCCNS, through regular meetings and symposiums, provides a forum for its members to discuss clinical and scientific matters involved in the neurologic practice of medicine.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $0

Program Service Revenue $308,848

Investment Income $0

Other Revenue $0

TOTAL REVENUE $308,848

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $233,056

Other Expenses $316,440

TOTAL EXPENSES $316,440

Year-over-Year Comparison

	2023	2022	Change
Revenue	$308,848	$249,739	+0.2%
Expenses	$316,440	$263,010	+0.2%
Net Income	$-7,592	$-13,271	-0.4%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Role	Reportable Comp	Other Comp	Total
Mazen Dimachike MD	Director	Officer Director	$0	$0	$0
Sarah Hon DO	President	Director	$0	$0	$0
Charles Donohoe MD	Director	Director	$0	$0	$0
Sean Gratton MD	Director	Director	$0	$0	$0
Kathryn Hedges MD	Director	Director	$0	$0	$0
Christine Boutwell MD	Director	Director	$0	$0	$0
Karin Olds MD	Director	Director	$0	$0	$0
Stephen Jarvis PhD	Director	Director	$0	$0	$0
Richard Barohn MD	Director	Director	$0	$0	$0
Abe Teferra	Treasurer	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$308,848	$316,440	$168,176	$-7,592
2022	$249,739	$263,010	$175,768	$-13,271

Kansas City Clinical Neuroscience Society Inc